Receiving Infusions News Today

First-of-its-kind drug. it offers real hope for slowing progression of the disease. here is kate snow. >> reporter: its the first time a drug meant to slow the progression of alzheimers disease has ever been granted full regulatory approval. in a clinical trial involving about 1800 patients in the early stages of alzheimers, the drug leqembi slowed cognitive decline by 27% over an 18-month period, compared to people who took a placebo. >> i really cannot overstate how important today is. this is...